Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2018

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2018
ENANTA PHARM (NASDAQ: ENTA) Delayed: 14.06 +0.69 (5.16%)
Previous Close $13.37    52 Week High $34.49 
Open $13.22    52 Week Low $20.39 
Day High $14.12    P/E N/A 
Day Low $12.92    EPS $-3.18 
Volume 401,621